ESID 2019

Wednesday 18th September 2019 at Brussels, Belgium


The 2019 Focused Meeting of the European Society for Immunodeficiencies (ESID 2019): Malignancy and PID will take place from September 18-21, in Brussels, Belgium.

The Meeting will focus on the fascinating intertwinement between primary immunodeficiencies, infections and malignancy, featuring the very best international speakers.

ESID 2019 will also include classics such as the Educational Day, Meet the Experts and the latest advances in our field.

You can already take part in the scientific programme and share your expertise with the world, by presenting your research in Brussels.


Review the topics and submit your abstract by April 30, 2019.

Visit the ESID 2019 website for more information: https://esidmeeting.org/

Stay tuned for more exciting ESID 2019 updates!


Event Details


Upcoming Events

Frontiers in Immunology (In-Person & Virtual)

Tuesday 11th April 2023 at New York Academy of Sciences

2023 International Day of Immunology

Saturday 29th April 2023

IUIS-SMI-FAIS Immuno-Morocco Course

Monday 5th June 2023 at Zephyr TargaTunisian Society of Immunology, Federation of African Immunological Societies (FAIS)

Memorial Symposium – Michael Sela

Wednesday 7th June 2023 at Science of Institute WeizmannIsraeli Society for Immunology

17th International Workshop on Langerhans Cells – and Related Myeloid Cells of the Skin

Thursday 8th June 2023 at Institut Cochin

FOCIS 2023 Annual Meeting

Tuesday 20th June 2023 at Boston Marriott Copley Place.

WCP2023 – 19th World Congress of Basic and Clinical Pharmacology

Sunday 2nd July 2023

Travel Award – IUIS/AAI Summer Introductory Course in Immunology

Tuesday 11th July 2023 at UCLA Meyer and Renee Luskin Conference CenterAmerican Association of Immunologists (AAI), Gender Equality Committee (GEC) and 1 more

Travel Award – IUIS/AAI Summer Advanced Course in Immunology

Sunday 23rd July 2023 at The Westin Copley PlaceAmerican Association of Immunologists (AAI), Gender Equality Committee (GEC) and 1 more